ERBB2 and ovarian mucinous neoplasm: Intratumoral heterogeneity among mucinous ovarian tumors, which previously seemed to be restricted to heterogeneity in ERBB2 status (observable in situ using FISH, CISH or IHC), presents a challenge for standard molecular analyses [13].